Patent details

EP1423105 Title: COMBINATIONS OF DMXAA AND OTHER ANTI-CANCER AGENTS

Basic Information

Publication number:
EP1423105
PCT Application Number:
PCT/GB/2002/004025
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027585629
PCT Publication Number:
WO/2003/020259
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS OF DMXAA AND OTHER ANTI-CANCER AGENTS
French Title of Invention:
COMBINAISONS COMPRENANT DU DXMAA ET D'AUTRES AGENTS ANTI-CANCEREUX
German Title of Invention:
ZUSAMMENSETZUNGEN AUS DMXAA UND ANDEREN ANTIKREBSMITTEL
SPC Number:

Dates

Filing date:
03/09/2002
Grant date:
03/12/2008
EP Publication Date:
03/12/2008
PCT Publication Date:
13/03/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/06/2004
EP B1 Publication Date:
03/12/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/09/2011
Expiration date:
03/09/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/09/2002
 
 

Name:
Cancer Research Technology Limited
Address:
Sardinia House, Sardinia Street London WC2A 3NL, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/12/2008
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WILSON William, Robert
Address:
New Zealand (NZ)

2

Name:
SIIM Bronwyn, Gae
Address:
New Zealand (NZ)

Priority

Priority Number:
0121285
Priority Date:
03/09/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/19;
Filing date Document type Number of pages